Case report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarate

BMC Neurology

Volumn 15, Issue 1, 2015, Pages

  Dammeier, Nele ^a   Schubert, Victoria ^a   Hauser, Till Karsten ^b   Bornemann, Antje ^c   Bischof, Felix ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

dimethyl fumarate; PML; Psoriasis treatment

Indexed keywords

ETIRACETAM; FUMADERM; MEFLOQUINE; MIRTAZAPINE; VIRUS DNA; FUMARIC ACID DIMETHYL ESTER;

ACUTE CONFUSION; ADULT; APHASIA; ARTICLE; BRAIN BIOPSY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; DRUG WITHDRAWAL; FEMALE; FOCAL EPILEPSY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JC VIRUS; LYMPHOCYTE COUNT; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSORIASIS; BRAIN; ISOLATION AND PURIFICATION; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; PATHOLOGY; POLYMERASE CHAIN REACTION;

BRAIN; DIMETHYL FUMARATE; FEMALE; HUMANS; JC VIRUS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 84936143734     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/s12883-015-0363-8     Document Type: Article

References (17)

1. Ferenczy MW, Marshall LJ, Nelson CD, Atwood WJ, Nath A, Khalili K, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev. 2012;25(3):471-506. doi:10.1128/CMR.05031-11 25/3/471 [pii].
2. Sweetser MT, Dawson KT, Bozic C. Manufacturer's response to case reports of PML. N Engl J Med. 2013;368(17):1659-61. doi: 10.1056/NEJMc1300283 .
3. van Oosten BW, Killestein J, Barkhof F, Polman CH, Wattjes MP. PML in a patient treated with dimethyl fumarate from a compounding pharmacy. N Engl J Med. 2013;368(17):1658-9. doi: 10.1056/NEJMc1215357 .
4. Stoppe M, Thoma E, Liebert UG, Major EO, Hoffmann KT, Classen J, et al. Cerebellar manifestation of PML under fumarate and after efalizumab treatment of psoriasis. J Neurol. 2014;261(5):1021-4. doi: 10.1007/s00415-014-7311-1 .
5. Nieuwkamp DJ, Murk JL, van Oosten BW, Cremers CH, Killestein J, Viveen MC, et al. PML in a patient without severe lymphocytopenia receiving dimethyl fumarate. N Engl J Med. 2015;372(15):1474-6. doi: 10.1056/NEJMc1413724 .
6. Helwa I, Patel R, Karempelis P, Kaddour-Djebbar I, Choudhary V, Bollag WB. The antipsoriatic agent monomethylfumarate has antiproliferative, prodifferentiative, and anti-inflammatory effects on keratinocytes. J Pharmacol Exp Ther. 2015;352(1):90-7. doi:10.1124/jpet.114.218818 jpet.114.218818 [pii].
7. idec b. Fachinformation Fumaderm. 2013. http://www.fachinfo.de/pdf/000847 .
8. Gold R, Kappos L, Arnold DL, Bar-Or A, Giovannoni G, Selmaj K, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. N Engl J Med. 2012;367(12):1098-107. doi: 10.1056/NEJMoa1114287 .
9. Ryschkewitsch C, Jensen P, Hou J, Fahle G, Fischer S, Major EO. Comparison of PCR-southern hybridization and quantitative real-time PCR for the detection of JC and BK viral nucleotide sequences in urine and cerebrospinal fluid. J Virol Methods. 2004;121(2):217-21. doi: 10.1016/j.jviromet.2004.06.021 .
10. Ermis U, Weis J, Schulz JB. PML in a patient treated with fumaric acid. N Engl J Med. 2013;368(17):1657-8. doi: 10.1056/NEJMc1211805 .
11. Sweetser MT, Dawson KT, Bozic C. Case reports of PML in patients treated for psoriasis. N Engl J Med. 2013;369(11):1082.
12. Bellizzi A, Nardis C, Anzivino E, Rodio D, Fioriti D, Mischitelli M, et al. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies. J Neurovirol. 2012;18(1):1-11. doi: 10.1007/s13365-012-0080-7 .
13. Kothary N, Diak IL, Brinker A, Bezabeh S, Avigan M, Dal PG. Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients. J Am Acad Dermatol. 2011;65(3):546-51. doi: 10.1016/j.jaad.2010.05.033 .
14. Koralnik IJ, Wuthrich C, Dang X, Rottnek M, Gurtman A, Simpson D, et al. JC virus granule cell neuronopathy: A novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol. 2005;57(4):576-80. doi: 10.1002/ana.20431 .
15. Schippling S, Kempf C, Buchele F, Jelcic I, Bozinov O, Bont A, et al. JC virus granule cell neuronopathy and GCN-IRIS under natalizumab treatment. Ann Neurol. 2013;74(4):622-6. doi: 10.1002/ana.23973 .
16. Wuthrich C, Dang X, Westmoreland S, McKay J, Maheshwari A, Anderson MP, et al. Fulminant JC virus encephalopathy with productive infection of cortical pyramidal neurons. Ann Neurol. 2009;65(6):742-8. doi: 10.1002/ana.21619 .
17. Agnihotri SP, Wuthrich C, Dang X, Nauen D, Karimi R, Viscidi R, et al. A fatal case of JC virus meningitis presenting with hydrocephalus in a human immunodeficiency virus-seronegative patient. Ann Neurol. 2014;76(1):140-7. doi: 10.1002/ana.24192 .